UK markets closed

Curaleaf Holdings, Inc. (CURLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
5.94+0.03 (+0.51%)
At close: 03:59PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • R
    All 4 MSO's reduce share price at 9:58. Just before that, looked like a good day coming! What is this called???
  • Z
    Investment is building a solid portfolio that you believe will create long term wealth
  • T
    I have been Holding for a while now, but the market dynamism is getting me really uncomfortable, i really need some help deciding. 🙏😔
  • J
    John M
    Lots of “mute” opportunities this evening.
  • P
    Curaleaf controls about 35% market share in NJ. NJ cannabis market is expected to grow from 250 million to 2 billion within the next few years. If Curaleaf captures even 10% of that growth, we're talking another 175 million in new revenue with a potential for nearly a billion more in revenue just from NJ. They are also squarely ensconced in NY where recreational is just getting started. Now think what happens when Florida legalizes recreational. Now think what happens when Euro goes legal? I can imagine revenues in excess of 10 billion within five years. This company is a monster in the making. As far as making profits, once reform gets going, taxes become more reasonable and the illicit market gets cut to size, big profits will follow. This is a 10 bagger.
  • T
    Three blind mice
    Im calling it the down ward trend is over.
  • B
    With the market rising, Cura and AUSA stocks are a great investment choice.
  • S
    Nice numbers! - Way to go Curaleaf team! You've got direction and discipline!
  • D
    Must see video interview with Boris.

    I listened to Trulieve CEO earlier this morning on earnings call and the contrast between her and Boris is striking. He really knows what he's talking about because of his lengthy experience, both here and in Europe. His decision to enter Europe will turn out to be most fortuitous. Very exciting interview. Enjoy.
    Curaleaf CEO Boris Jordan Talks Latest Earnings
  • T
    Three blind mice
    Boris Jordan has the advantage in Europe when it comes to the top 5 MSO. First he has 30 years experience working there and knows how they operate. He has made several moves there and is the only MSO to do so. Europe has 750 million people, where as USA has 350. Europe allows tax right offs. Germany is medical legal and will be recreational legal very soon. Germany also allows insurance to pay or medical pot. Germany is largest economy in Europe and CURLF is there. By the time the rest of the MSO make their move to Europe if they ever do they will pay alot more to invest than CURLF. These points ive made is why most of my shares are in CURLF, but i do have shares in the other main MSO as im sure they will do well. I am curious to see which MSO will make a move to Europe and how long till they do.
  • B
    Have you guys ever heard of ( The picks on there are way better than CURLF
  • A
    They show a loss of 0.04 / share because a lot of the expenses are not deductible in USA YET.
    They topped the sales, EBITDA and gross margins.
    You simply cannot ask for more
  • m
    Thank You Mr. Jordan, and team. Buttoned up and a fantastic call. Michael
  • R
    I’m long investor been up / down on Paper. Looking at move info Europe and expanding in us state by state. If you can afford multi year hold CURLF at good entry point and growing well. Catalyst for big rewards wait on Feds passing -Fair Banking then legalizing - up to 39 states with some form of legal cannabis use- the train has left the station.
    Do your DD & GL
  • M
    Matt Darin keep it up
  • K
    Look at the New York Tent City Green Houses __ what a joke !
  • M
    There are different levels to the cannabis industry, just like a lot of products we buy, sunglasses as example. Products will continue to grow and continue to get better.
  • j
    Cowen analyst Vivien Azer on Tuesday reiterated her outperform rating on Curaleaf Holdings Inc. and trimmed her 2023 revenue estimate to $1.64 billion from $1.65 billion based on the cannabis company's shift away from its lower margin wholesale business. Curaleaf's 8% growth in sales over the previous quarter beat Cowen's forecast of 2%. Gross margin was 250 basis points above Cowen's projection of 52% and adjusted Ebitda of 25.5% beat Cowen's estimate by 220 basis points. Shares
  • r
    $350 million qtr would make me happy